Back
Brainstorm Cell Therapeutics Vs. Nike Industry Stock Comparison
Sell
30
BCLI
Brainstorm Cell Therapeutics
Last Price:
0.35
Seasonality Move:
27.17%
Sell
17
NKE
Nike
Last Price:
76.06
Seasonality Move:
6.25%
Sell
30
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $0.36. The Score for BCLI is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Nike (NKE)
is a Sell
Is Nike a Buy, Sell or Hold?
- The current Nike [NKE] share price is $76.83. The Score for NKE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- NKE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $0.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight buying pressure.
BCLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 37.85 | Sell |
| Chaikin Money Flow: | 199201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.38 - 0.48) | Sell |
| Bollinger Bands (100): | (0.35 - 0.57) | Sell |
NKE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.29 | Sell |
| Relative Strength Index (14 RSI): | 22.31 | Sell |
| Chaikin Money Flow: | 35382688 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (87.89 - 98.33) | Sell |
| Bollinger Bands (100): | (90.25 - 101.25) | Sell |
BCLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.38 | Sell |
| 20-day SMA: | 0.41 | Sell |
| 50-day SMA: | 0.46 | Sell |
| 200-day SMA: | 0.38 | Sell |
| 8-day EMA: | 0.38 | Sell |
| 20-day EMA: | 0.41 | Sell |
| 50-day EMA: | 0.45 | Sell |
| 200-day EMA: | 0.66 | Sell |
NKE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.64 | Sell |
| 20-day SMA: | 93.19 | Sell |
| 50-day SMA: | 92.98 | Sell |
| 200-day SMA: | 100.11 | Sell |
| 8-day EMA: | 87.55 | Sell |
| 20-day EMA: | 91.33 | Sell |
| 50-day EMA: | 93.16 | Sell |
| 200-day EMA: | 99.5 | Sell |
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.02 per share.
Nike Earnings Growth & NKE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.48 per share, and a decrease next year of $0.40 per share.
Brainstorm Cell Therapeutics Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nike Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||